期刊文献+

冠心病患者血清脂蛋白(a)水平临床分析 被引量:6

The Clinical Analysis of Lipoprotein(a) Levels in Patients with Coronary Artery Disease
暂未订购
导出
摘要 目的:评价血清脂蛋白(a)[Lp(a)]在冠心病(CHD)诊疗中的地位和作用。方法:取250例患者血清进行测定Lp(a)和总胆固醇(TC)、甘油三脂(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C),其中正常组63例,冠心病组89例,高血压病组52例,其它类心脏病组46例。结果:①冠心病组血清Lp(a)较其他3组均显著升高(P<0.01),高血压组和其它类心脏病组与正常组Lp水平比较,无显著统计学差异(P>0.05);②冠心病单支病变组、2支病变组、2支以上病变组各组间血清Lp(a)水平比较差异均有统计学意义;③冠心病非急性心肌梗死患者与急性心肌梗死患者血清Lp(a)浓度无明显差异(P>0.05);④多因素逐步回归分析表明,Lp(a)与TG、TC、HDL-C之间无显著相关。结论:高Lp(a)水平是冠心病的独立危险因子,对于预测冠心病的发生有一定的价值,但对于预测冠心病急性心血管病事件的发生却未见明显的优势。 Objective: To explore the diagnostic value of lipoprotein(a)[Lp (a)] in coronary heart disease. Methods: Venous blood samples were collected from 250 persons for measuring serum levels of Lp(a),total cholesterol(TC),high-density lipoprotein cholesterol (HDL-C),low-density lipoprotein cholesterol(LDL-C) and triglycerides (TG). Among them there were 63 normal persons,89 patients with coronary heart disease 52 with hypertension and and 46 with others cardiovascular diseases. Results: (1) Compared with other three groups, Lp(a) levels were significantly higher in coronary artery disease group(P〈0.01);(2)The levels of Lp(a) were higher with the extent of coronary stenosis;(3)Serum Lp(a) levles did not differ between acute myocardial infarction and stable coronary artery disease(P〉0. 05) ;(4)No correlations were be observed between Lp (a) level and serum levels of total cholesterol (TC), high-density lipoprotein cholesterol(HDL-C) or triglycerides (TG). Conclusion: High serum Lp(a)level is an independent risk factor for cardiovascular disease and can be used for predicting coronary artery disease, but it has no advantage in predicting future cardiovascular events.
出处 《实用临床医学(江西)》 CAS 2006年第6期29-31,共3页 Practical Clinical Medicine
关键词 最心病 脂蛋白(a) 危险因子 coronary heart disease lipoprotein(a) risk factor
  • 相关文献

参考文献10

  • 1COUGHLAN B J,SORRENTINO M J.Does Hypertriglyceridemia Increase Risk for CAD? Growing Evidence Suggests it Plays a Role[J].Postgrad Med,2000,108(7):77-84.
  • 2DAHLEN G H.Lp(a) lipoprotein in cardiovascular disease[J].Atherosclerosis,1994,108(2):111-26.
  • 3KWITEROVICH P O Jr,VIRGIL D G,GARRETT E S,et al.Lipoprotein Heterogeneity at Birth:Influence of Gestational Age and Race on Lipoprotein Subclasses and Lp(a) Lipoprotein[J].Ethn Dis,2004,14(3):351-359.
  • 4冯宁,冯宗忱.小、密低密度脂蛋白与冠心病[J].中华心血管病杂志,1997,25(3):237-240. 被引量:41
  • 5McLean J W,TOMLINSON J E,KUANG WJ,et al.cDNA Sequence of Human Apolipoprotein(a) is Homologous to Plasminogen[J].Nature,1987,330(6 144):132-137.
  • 6CANTIN B,DESPRES J P,LAMARCHE B,et al.Association of Fibrinogen and Lipoprotein(a) as a Coronary Heart Disease Risk Factor in Men(The Quebec Cardiovascular Study)[J].Am J Cardiol,2002,89(6):662-666.
  • 7O'Neil C H,BOFFA M B,HANCOCK M A,et al.Stimulation of Vascular Smooth Muscle Cell Proliferation and Migration by Apolipoprotein(a) is Dependent on Inhibition of Transforming Growth Factor-beta Activation and on the Presence of Kringle IV Type 9[J].J Biol Chem,2004,279(53):55 187-55 195.
  • 8BOWIE E J.Lipid-related Clotting Reactions of Clinical Significance[J].Arch Pathol Lab Med,1992,116(12):1 345-1 349.
  • 9TEWARI S,GARG N,KAPOOR A,et al.Association of Common Carotid Intima-media Thickness and Lipoprotein(a) with Coronary Artery Disease[J].Indian Heart J,2004,56(6):642-645.
  • 10TSIMIKAS S,BRILAKIS E S,MILLER E R,et al.Oxidized Phospholipids,Lp(a)Lipoprotein,and Coronary ARrtery Disease[J].N Engl J Med,2005,353(1):46-57.

共引文献40

同被引文献61

  • 1刘学波,王克强,葛均波.细胞迁移机制在冠状动脉支架再狭窄作用的研究进展[J].心血管病学进展,2004,25(6):436-439. 被引量:8
  • 2尹航,汪丽蕙,霍勇,彭旭,夏春芳,唐朝枢.粘着斑激酶和丝裂原活化蛋白激酶对纤粘连蛋白诱导平滑肌细胞迁移和增殖的影响[J].中华医学杂志,2002,82(9):622-625. 被引量:12
  • 3韦立新,唐庆贺,孙璐,石怀银,郭爱桃,游联璧.人体冠状动脉粥样硬化斑块中氧化低密度脂蛋白和新生血管与斑块稳定性的关系[J].中华病理学杂志,2006,35(3):138-141. 被引量:37
  • 4Elezi S, Kastrati A, Neumann FJ, et al. Vessel size and long - term outcome after coronary stent placement [ J]. Circulation, 1998,98 (18) :1875-1880.
  • 5Colombo A, Hall P, Nakamura S, et al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance [ J ]. Circulation, 1995,91 ( 6 ) : 1676-1688.
  • 6Kamitani T, Taniguchi T, Miyai N ,et al. Association between plasma lipoprotein(a) concentration and restenosis after stent implantation[ J]. Circ J,2005,69 (6) :644-649.
  • 7Biemond B J, Friederich PW, Koschinsky ML, et al. Apolipoprotein (a) attenuates endogenous fibrinolysis in tbe rabbit jugular vein thrombosis model in vivo[ J]. Circulation, 1997,96 ( 5 ) : 1612-1615.
  • 8Grainger D J, Metcalfe JC. Transforming growth factor-beta: the key to understanding lipoprotein ( a ) [ J ]. Curr Opin Lipidol, 1995,6 (2) :81-85.
  • 9Miyata M, Biro S, Kaieda H,et al. Lipoprotein(a) stimulates the proliferation of cultured human arterial smooth muscle cells through two pathways[ J ]. FEBS Lett, 1995,377 (3) :493-496.
  • 10Kanemitsu S, Takekoshi N, Matsui S, et al, Short-term and long- term effects of low-density lipoprotein (LDL) apheresis on restenosis after percutaneous transluminal coronary angioplasty (PTCA) : is lowering Lp(a) by LDL apheresis effective on restenosis after PTCA [ J]. Ther Apher, 1998,2 ( 1 ) :65-70.

引证文献6

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部